Am J Pathol

1. NEWBERRY EP, Molitor EA, Liu A, Chong K, et al
   Impaired hepatic VLDL secretion promotes tumorigenesis and is accelerated with Fabp1 deletion.
   Am J Pathol. 2024 Feb 26:S0002-9440(24)00074.
   

   >> Share

   
   

   
   Biochem Biophys Res Commun

2. WU M, Tie M, Hu L, Yang Y, et al
   Fatty liver disease protective MTARC1 p.A165T variant reduces the protein stability of MTARC1.
   Biochem Biophys Res Commun. 2024;702:149655.
   

   >> Share

   
   

   
   BMC Cancer

3. DA X, Cao B, Mo J, Xiang Y, et al
   Inhibition of growth of hepatocellular carcinoma by co-delivery of anti-PD-1 antibody and sorafenib using biomimetic nano-platelets.
   BMC Cancer. 2024;24:273.
   

   >> Share

   
   
4. OUYANG Y, Gu Y, Zhang X, Huang Y, et al
   AMPKalpha2 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma.
   BMC Cancer. 2024;24:276.
   

   >> Share

   
   
5. JIN Y, Ren H, Yue Q, Wu W, et al
   Surrogacy of one-year survival for overall survival in advanced hepatocellular carcinoma.
   BMC Cancer. 2024;24:258.
   

   >> Share

   
   

   
   BMC Gastroenterol

6. LIU JP, Song SH, Shi PM, Qin XY, et al
   miR-541 is associated with the prognosis of liver cirrhosis and directly targets JAG2 to inhibit the activation of hepatic stellate cells.
   BMC Gastroenterol. 2024;24:84.
   

   >> Share

   
   
7. WANG M, Tang S, Li G, Huang Z, et al
   Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients.
   BMC Gastroenterol. 2024;24:81.
   

   >> Share

   
   
8. ZHOU J, Ye D, Zhang S, Ding J, et al
   The impact of Karnofsky performance status on prognosis of patients with hepatocellular carcinoma in liver transplantation.
   BMC Gastroenterol. 2024;24:85.
   

   >> Share

   
   
9. WANG Z, Liu Z, Zheng J, Huang L, et al
   The effects of low-dose IL-2 on Th17/Treg cell imbalance in primary biliary cholangitis mouse models.
   BMC Gastroenterol. 2024;24:87.
   

   >> Share

   
   
10. RITACCIO G, Barritt Iv AS, Conklin JL, Richardson DR, et al
    Scoping review of values elicitation tools for treatment decisions in hepatocellular carcinoma.
    BMC Gastroenterol. 2024;24:90.
    

    >> Share

    
    

    
    Cancer Res

11. WANG Y, Cheng C, Lu Y, Lian Z, et al
    beta-catenin Activation Reprograms Ammonia Metabolism to Promote Senescence Resistance in Hepatocellular Carcinoma.
    Cancer Res. 2024 Feb 28. doi: 10.1158/0008-5472.CAN-23-0673.
    

    >> Share

    
    

    
    Dig Dis Sci

12. KALAITZAKIS ZE, Giahnakis E, Koutroubakis IE, Mouzas IA, et al
    Bariatric Nutritional Intervention in Obese Patients with Compensated Liver Cirrhosis: A Four-Year Prospective Study.
    Dig Dis Sci. 2024 Feb 27. doi: 10.1007/s10620-023-08223.
    

    >> Share

    
    

    
    Gastroenterology

13. HOLTZ LR, DeBosch BJ
    Deploying Lactulose as a Prebiotic to Reduce Complications of Chronic Liver Disease.
    Gastroenterology. 2024;166:534-535.
    

    >> Share

    
    
14. URIAS E, Tedesco NR, Oliveri A, Raut C, et al
    PNPLA3 Risk Allele Association With ALT Response to Semaglutide Treatment.
    Gastroenterology. 2024;166:515-517.
    

    >> Share

    
    
15. GAO F, Seto WK, Zheng MH
    Preventing Overdiagnosis of Nonalcoholic Fatty Liver Disease: Established Cutoff Values for Transient Elastography Are Needed.
    Gastroenterology. 2024;166:541-542.
    

    >> Share

    
    
16. AN T, Liu L, Li X
    Factors Associated With the Influence of Liver Fibrosis Should Be Fully Considered.
    Gastroenterology. 2024;166:540-541.
    

    >> Share

    
    
17. CHEN J, Feng W, Sun M, Huang W, et al
    TGF-beta1 Induced SOX18 Elevation Promotes Hepatocellular Carcinoma Progression and Metastasis through Transcriptionally Upregulating PD-L1 and CXCL12.
    Gastroenterology. 2024 Feb 26:S0016-5085(24)00187.
    

    >> Share

    
    

    
    Gut

18. QIAN Z, Liang J, Huang R, Song W, et al
    HBV integrations reshaping genomic structures promote hepatocellular carcinoma.
    Gut. 2024 Feb 23:gutjnl-2023-330414. doi: 10.1136/gutjnl-2023-330414.
    

    >> Share

    
    
19. HUNTER H, Johnston AJ, Said W, Wong NA, et al
    Colonic spider naevi in a middle-aged man.
    Gut. 2024;73:441-520.
    

    >> Share

    
    
20. GREEN BL, Myojin Y, Ma C, Ruf B, et al
    Immunosuppressive CD29(+) Treg accumulation in the liver in mice on checkpoint inhibitor therapy.
    Gut. 2024;73:509-520.
    

    >> Share

    
    
21. CUBERO FJ, Sarobe P, Tiegs G
    Advancing with cancer immunotherapeutics: CD29(+) regulatory T cell antagonism.
    Gut. 2024;73:391-392.
    

    >> Share

    
    
22. LEE HH, Lee HA, Kim EJ, Kim HY, et al
    Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease.
    Gut. 2024;73:533-540.
    

    >> Share

    
    

    
    J Gastroenterol

23. WANG J, Zhang H, Chen L, Fu K, et al
    CircDCBLD2 alleviates liver fibrosis by regulating ferroptosis via facilitating STUB1-mediated PARK7 ubiquitination degradation.
    J Gastroenterol. 2024;59:229-249.
    

    >> Share

    
    
24. WU C, Li J, Jia H, Zhao J, et al
    Indoleamine 2,3-dioxygenase 1-mediated iron metabolism in macrophages contributes to lipid deposition in nonalcoholic steatohepatitis.
    J Gastroenterol. 2024 Feb 24. doi: 10.1007/s00535-024-02082.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

25. 
    Correction to "Hepatobiliary and Pancreatic: Challenges in the diagnosis of hepatic nodules in patients with alcoholic liver cirrhosis".
    J Gastroenterol Hepatol. 2024 Feb 25. doi: 10.1111/jgh.16529.
    

    >> Share

    
    
26. TADA T, Kumada T, Hiraoka A, Kariyama K, et al
    mADRES predicts hepatocellular carcinoma development in patients with hepatitis C virus who achieved sustained virological response.
    J Gastroenterol Hepatol. 2024 Feb 25. doi: 10.1111/jgh.16512.
    

    >> Share

    
    

    
    J Hepatol

27. XIE P, Yu M, Zhang B, Yu Q, et al
    CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.
    J Hepatol. 2024 Feb 23:S0168-8278(24)00129-6. doi: 10.1016/j.jhep.2024.
    

    >> Share

    
    

    
    N Engl J Med

28. ASSIS DN
    Advancing Second-Line Treatment for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:853-854.
    

    >> Share

    
    
29. HIRSCHFIELD GM, Bowlus CL, Mayo MJ, Kremer AE, et al
    A Phase 3 Trial of Seladelpar in Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:783-794.
    

    >> Share

    
    
30. SCHNABL B
    PPAR Agonists in Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:855-858.
    

    >> Share

    
    

    
    Oncogene

31. ZHANG T, Zhao F, Zhang Y, Shi JH, et al
    Targeting the IRE1alpha-XBP1s axis confers selective vulnerability in hepatocellular carcinoma with activated Wnt signaling.
    Oncogene. 2024 Feb 28. doi: 10.1038/s41388-024-02988.
    

    >> Share

    
    
32. FENG Z, Yin J, Zhang Z, Chen Z, et al
    O-GlcNAcylation of E3 ubiquitin ligase SKP2 promotes hepatocellular carcinoma proliferation.
    Oncogene. 2024 Feb 23. doi: 10.1038/s41388-024-02977.
    

    >> Share

    
    

    
    PLoS One

33. LADNER DP, Gmeiner M, Hasjim BJ, Mazumder N, et al
    Increasing prevalence of cirrhosis among insured adults in the United States, 2012-2018.
    PLoS One. 2024;19:e0298887.
    

    >> Share

    
    
34. ELGUEZABAL RODELO RG, Porchia LM, Torres-Rasgado E, Lopez-Bayghen E, et al
    Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
    PLoS One. 2024;19:e0298662.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

35. DOU Q, Grant AK, Coutinto de Souza P, Moussa M, et al
    Characterizing Metabolic Heterogeneity of Hepatocellular Carcinoma with Hyperpolarized (13)C Pyruvate MRI and Mass Spectrometry.
    Radiol Imaging Cancer. 2024;6:e230056.
    

    >> Share

    
    

    
    Radiology

36. CANNELLA R, Matteini F, Dioguardi Burgio M, Sartoris R, et al
    Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
    Radiology. 2024;310:e231160.
    

    >> Share

    
    
37. KARTALIS N, Grigoriadis A
    LI-RADS in Patients with Solitary Resected Hepatocellular Carcinoma: Glancing beyond Diagnosis.
    Radiology. 2024;310:e240161.
    

    >> Share

    
    

    
    Transplant Proc

38. COSTA PEG, Garcia JHP, Coelho GR, Barros MAP, et al
    Hepatocellular Carcinoma in Ceara: Epidemiology and Treatment in a Reference Liver Transplant Center in Northeast Brazil.
    Transplant Proc. 2024 Feb 28:S0041-1345(24)00009.
    

    >> Share

    
    

    
    Transplantation

39. BECKER EC, Siddique O, O'Sullivan DM, Dar W, et al
    Disparities in Liver Transplantation for Nonalcoholic Steatohepatitis in Women.
    Transplantation. 2024 Feb 29. doi: 10.1097/TP.0000000000004964.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share